EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Performance of Donor‐Derived Cell‐Free DNA in Surveillance and For‐Cause Biopsies in Pediatric Kidney Transplant Recipients

Stella Kilduff iD, Joseph Fishbein, Carlos Becerril-Romero, Matthew Switalski, Debora Matossian iD, Priya S Verghese iD

Pediatric Transplantation · 2025-12 · 29 (8)

DOI: 10.1111/petr.70215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, online erschienen am 30.10.2025. Verfasst von Stella Kilduff und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Graft Rejection, Cell-Free Nucleic Acids, Kidney. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Siragusa Transplantation Center at Ann & Robert H. Lurie Children's Hospital of Chicago.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Donor‐derived cell‐free DNA (dd‐cfDNA), a biomarker demonstrated to increase with allograft injury, has been considered a possible diagnostic tool for allograft rejection in place of the current gold standard which is invasive kidney biopsies. We tested whether dd‐cfDNA levels were predictive of rejection in our single‐center cohort of pediatric kidney transplant (KT) recipients.

Methods

All primary pediatric KT recipients that had a dd‐cfDNA level obtained within a month of any kidney biopsy, either surveillance or for‐cause were included. Descriptive analysis was performed stratified by rejection status. Univariate analysis was performed to assess the association between median dd‐cfDNA levels and rejection by each biopsy time point. dd‐cfDNA levels were then further stratified by rejection type (no rejection, T‐cell mediated, antibody mediated, or mixed). Diagnostic performance metrics of dd‐cfDNA for detecting rejection were evaluated.

Results

Forty pediatric KT recipients had 44 biopsies, 21 (48%) of which demonstrated rejection. Acute cellular, antibody‐mediated, and mixed rejection occurred in 12 (57%), 6 (29%), and 3 (14%) respectively. The median dd‐cfDNA level at the time of biopsy in those with and without rejection was 1.7 (95% CI: 0.2, 3.3) and 0.3 (95% CI: 0.2, 0.7), respectively ( p = 0.15). dd‐cfDNA levels prior to for‐cause biopsies were significantly higher in patients with rejection (0.3 vs. 2.7; p = 0.02). dd‐cfDNA levels at surveillance biopsies did not differ significantly by rejection status or type of rejection. dd‐cfDNA levels ≥ 1 diagnosed rejection with a sensitivity of 52% and specificity of 83%.

Conclusions

Elevated dd‐cfDNA levels were associated with rejection in for‐cause biopsies but not in surveillance biopsies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationGraft RejectionCell-Free Nucleic AcidsKidneyHumansMaleChildFemaleBiopsyAdolescentChild, PreschoolBiomarkersTissue DonorsRetrospective StudiesInfant

Stichwörter der Autor:innen

donor‐derived cell‐free DNAkidney transplantationpediatricrejection

Substanzen

Cell-Free Nucleic AcidsBiomarkers

Autor:innen und Institutionen

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

ORCID-Profile: Stella Kilduff, Debora Matossian, Priya S Verghese

Förderung

  • Siragusa Transplantation Center at Ann & Robert H. Lurie Children's Hospital of Chicago

Zitieren

APA

Kilduff, S., Fishbein, J., Becerril-Romero, C., Switalski, M., Matossian, D., & Verghese, P. S. (2025). Performance of Donor‐Derived Cell‐Free DNA in Surveillance and For‐Cause Biopsies in Pediatric Kidney Transplant Recipients. Pediatric Transplantation, 29(8). https://doi.org/10.1111/petr.70215

Vancouver

Kilduff S, Fishbein J, Becerril-Romero C, Switalski M, Matossian D, Verghese PS. Performance of Donor‐Derived Cell‐Free DNA in Surveillance and For‐Cause Biopsies in Pediatric Kidney Transplant Recipients. Pediatric Transplantation. 2025;29(8). doi:10.1111/petr.70215

BibTeX
@article{Kilduff2025,
  author = {Kilduff, Stella and Fishbein, Joseph and Becerril-Romero, Carlos and Switalski, Matthew and Matossian, Debora and Verghese, Priya S},
  title = {Performance of Donor‐Derived Cell‐Free DNA in Surveillance and For‐Cause Biopsies in Pediatric Kidney Transplant Recipients},
  journal = {Pediatric Transplantation},
  year = {2025},
  volume = {29},
  number = {8},
  doi = {10.1111/petr.70215}
}
Kostenlos starten →